News Buzz
Check out the latest Sanshi buzz below.
Dr. Murali Addepalli, VP & CSO, delivered a speaker session, “The Code is the Cure” at the 3rd Global Biologics India Conference held in Hyderabad on 22nd – 23rd April. The session focused on Programmable Immune Infrastructure beyond Oncology extending into Auto-Immune, Fibrosis and Infectious Disease.
He also highlighted Sanshi’s proprietary end-to-end Injectable CAR Sequence Design Platform, PTIm-CAR™. This platform enables development from concept to FASTA-ready sequences with expression kinetics, CMC prediction and TME remodeling.
Sanshi Bio exhibited at the 23rd edition of BioAsia, held in Hyderabad on February 17–18, 2026. Visitors to the booth had engaging discussions around Sanshi’s revolutionary AI platform for biologics expediting research & development.
Rethink Your Drug Discovery and Development Projects
Leverage our Amplified Intelligence for optimized design and development of therapeutics
True to its Sanskrit origin—signifying refinement and mastery—SANSHI is guided by four pillars: Integrity, Quality, Expertise, and Excellence.
Follow Us
- Registered Office:
- 142, TNH, Lakshmi Nagar Colony, Kompally, Hyderabad 500014
- +91 9959161519
- bd@sanshibs.com